BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Nosology
,
Bleomycin
,
rs4950928
,
PDX1
,
cell-cell adhesion
,
Lung cancer
,
Heart
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Human papillomavirus 16
Summary
General Info
Curated Studies
Most Correlated Studies
Primary skin fibroblasts overexpressing E6/E7 genes of HPV16, HPV18, HPV38b, HPV107 and HPV122
Neonatal foreskin keratinocytes infected with E2 proteins of human papillomavirus 16 and 18
Dendritic cells and monocytes treated with different vaccines and TLR ligands
Gene expression signature of HPV in head and neck squamous cell carcinoma
Oral keratinocytes overexpressing human papillomavirus type 16 (HPV16) E6 and E7 oncogenes
Explore Curated Studies Results
Literature
Most Relevant Literature
CRISPR-Cas12a-mediated dual-enzyme cascade amplification for sensitive colorimetric detection of HPV…
Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis.
A Cas12a ortholog with distinct TTNA PAM enables sensitive detection of HPV16/18.
Sensitive and Amplification-Free Electrochemiluminescence Biosensor for HPV-16 Detection Based on CR…
Role of HPV16 E1 in cervical carcinogenesis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolesce…
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolesce…
A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females
Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ